熱門資訊> 正文
Lexeo Therapeutics通过私募融资8000万美元
2025-05-28 01:56
- Lexeo Therapeutics (NASDAQ:LXEO) has secured approximately $80M through a private placement with institutional and healthcare-focused investors.
- As part of the deal, Lexeo will sell 20.8M shares of common stock or pre-funded warrants for 7M shares.
- Each share comes with a warrant to purchase half a share of common stock, and the purchase price per share and accompanying warrant is $2.88.
- The funding, along with Lexeo’s existing cash, cash equivalents, and marketable securities, is expected to support the company’s operations and capital needs into 2028.
More on Lexeo Therapeutics
- Lexeo: Alignment Gained With FDA Brings Further LX2006 Program Advancement
- Top 10 Russell 2000 weekly gainers and losers as Wall Street crashes
- Seeking Alpha’s Quant Rating on Lexeo Therapeutics
- Historical earnings data for Lexeo Therapeutics
- Financial information for Lexeo Therapeutics
推薦文章
新股暗盤 | 大行科工大漲100%！中籤一手賺4950港元
新股申購 | 「全球激光雷達龍頭」禾賽-W正在招股！一手入場費4605.99港元
華盛早報 | 大動作！特斯拉AI芯片+人型機器人，馬斯克發聲！禾賽今日招股；恆指成份股調整今日生效
港股周報丨瘋狂掃貨！北水年內淨流入港股超萬億港元；創新葯概念狂飆，三生製藥周漲超22%
美股機會日報 | 8月非農大幅低於預期！納指期貨短線拉漲約0.7%；特斯拉盤前漲近2%
一周財經日曆 | 事關降息！中美5月CPI、PPI重磅出爐！新股「超購王」大行科工下周上市
高盛：降新鴻基地產目標價至96港元 評級「買入」
Lululemon Athletica連續第二次下調全年業績指引 盤后股價一度暴跌超15%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
